Skip to main content
. Author manuscript; available in PMC: 2017 Apr 13.
Published in final edited form as: Nano Lett. 2016 Mar 1;16(4):2248–2253. doi: 10.1021/acs.nanolett.5b04517

Figure 3.

Figure 3

(A) Relative MTRasym spectra for an ROI enclosing the brain tumor at 60 min postintratumoral infusion of G5-SA-D-Ac dendrimer and control PBS (B) % of tumor covered assuming pixels with MTRasym ≥ −0.035 contain G5-SA-D-Ac dendrimer.